Literature DB >> 26726827

Ultra-High-Throughput Structure-Based Virtual Screening for Small-Molecule Inhibitors of Protein-Protein Interactions.

David K Johnson1, John Karanicolas1.   

Abstract

Protein-protein interactions play important roles in virtually all cellular processes, making them enticing targets for modulation by small-molecule therapeutics: specific examples have been well validated in diseases ranging from cancer and autoimmune disorders, to bacterial and viral infections. Despite several notable successes, however, overall these remain a very challenging target class. Protein interaction sites are especially challenging for computational approaches, because the target protein surface often undergoes a conformational change to enable ligand binding: this confounds traditional approaches for virtual screening. Through previous studies, we demonstrated that biased "pocket optimization" simulations could be used to build collections of low-energy pocket-containing conformations, starting from an unbound protein structure. Here, we demonstrate that these pockets can further be used to identify ligands that complement the protein surface. To do so, we first build from a given pocket its "exemplar": a perfect, but nonphysical, pseudoligand that would optimally match the shape and chemical features of the pocket. In our previous studies, we used these exemplars to quantitatively compare protein surface pockets to one another. Here, we now introduce this exemplar as a template for pharmacophore-based screening of chemical libraries. Through a series of benchmark experiments, we demonstrate that this approach exhibits comparable performance as traditional docking methods for identifying known inhibitors acting at protein interaction sites. However, because this approach is predicated on ligand/exemplar overlays, and thus does not require explicit calculation of protein-ligand interactions, exemplar screening provides a tremendous speed advantage over docking: 6 million compounds can be screened in about 15 min on a single 16-core, dual-GPU computer. The extreme speed at which large compound libraries can be traversed easily enables screening against a "pocket-optimized" ensemble of protein conformations, which in turn facilitates identification of more diverse classes of active compounds for a given protein target.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26726827      PMCID: PMC4765363          DOI: 10.1021/acs.jcim.5b00572

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  82 in total

1.  Do structurally similar molecules have similar biological activity?

Authors:  Yvonne C Martin; James L Kofron; Linda M Traphagen
Journal:  J Med Chem       Date:  2002-09-12       Impact factor: 7.446

2.  GPCR structure-based virtual screening approach for CB2 antagonist search.

Authors:  Jian-Zhong Chen; Junmei Wang; Xiang-Qun Xie
Journal:  J Chem Inf Model       Date:  2007-06-20       Impact factor: 4.956

3.  Atomic interactions and profile of small molecules disrupting protein-protein interfaces: the TIMBAL database.

Authors:  Alícia P Higueruelo; Adrian Schreyer; G Richard J Bickerton; Will R Pitt; Colin R Groom; Tom L Blundell
Journal:  Chem Biol Drug Des       Date:  2009-11       Impact factor: 2.817

Review 4.  Structure-based druggability assessment--identifying suitable targets for small molecule therapeutics.

Authors:  Eric B Fauman; Brajesh K Rai; Enoch S Huang
Journal:  Curr Opin Chem Biol       Date:  2011-06-23       Impact factor: 8.822

5.  Simplified receptor based pharmacophore approach to retrieve potent PTP-LAR inhibitors using apoenzyme.

Authors:  Dara Ajay; M Elizabeth Sobhia
Journal:  Curr Comput Aided Drug Des       Date:  2011-09-01       Impact factor: 1.606

6.  Setting the record straight: the origin of the pharmacophore concept.

Authors:  Osman F Güner; J Phillip Bowen
Journal:  J Chem Inf Model       Date:  2014-04-18       Impact factor: 4.956

7.  Molecular orbital calculation of preferred conformations of acetylcholine, muscarine, and muscarone.

Authors:  L B Kier
Journal:  Mol Pharmacol       Date:  1967-09       Impact factor: 4.436

8.  Virtual screening for inhibitors of human aldose reductase.

Authors:  Oliver Kraemer; Isabelle Hazemann; Alberto D Podjarny; Gerhard Klebe
Journal:  Proteins       Date:  2004-06-01

9.  Crystal structure of the E2 transactivation domain of human papillomavirus type 11 bound to a protein interaction inhibitor.

Authors:  Yong Wang; René Coulombe; Dale R Cameron; Louise Thauvette; Marie-Josée Massariol; Lynn M Amon; Dominique Fink; Steve Titolo; Ewald Welchner; Christiane Yoakim; Jacques Archambault; Peter W White
Journal:  J Biol Chem       Date:  2003-11-22       Impact factor: 5.157

10.  Selectivity by small-molecule inhibitors of protein interactions can be driven by protein surface fluctuations.

Authors:  David K Johnson; John Karanicolas
Journal:  PLoS Comput Biol       Date:  2015-02-23       Impact factor: 4.475

View more
  11 in total

1.  Discovery of Nicotinamide Adenine Dinucleotide Binding Proteins in the Escherichia coli Proteome Using a Combined Energetic- and Structural-Bioinformatics-Based Approach.

Authors:  Lingfei Zeng; Woong-Hee Shin; Xiaolei Zhu; Sung Hoon Park; Chiwook Park; W Andy Tao; Daisuke Kihara
Journal:  J Proteome Res       Date:  2016-12-05       Impact factor: 4.466

2.  Web-accessible molecular modeling with Rosetta: The Rosetta Online Server that Includes Everyone (ROSIE).

Authors:  Rocco Moretti; Sergey Lyskov; Rhiju Das; Jens Meiler; Jeffrey J Gray
Journal:  Protein Sci       Date:  2017-10-27       Impact factor: 6.725

3.  Enabling the hypothesis-driven prioritization of ligand candidates in big databases: Screenlamp and its application to GPCR inhibitor discovery for invasive species control.

Authors:  Sebastian Raschka; Anne M Scott; Nan Liu; Santosh Gunturu; Mar Huertas; Weiming Li; Leslie A Kuhn
Journal:  J Comput Aided Mol Des       Date:  2018-01-30       Impact factor: 3.686

Review 4.  Computational Tools and Strategies to Develop Peptide-Based Inhibitors of Protein-Protein Interactions.

Authors:  Maxence Delaunay; Tâp Ha-Duong
Journal:  Methods Mol Biol       Date:  2022

5.  How Structural Biology Has Directly Impacted Our Understanding of P2X Receptor Function and Gating.

Authors:  Steven E Mansoor
Journal:  Methods Mol Biol       Date:  2022

6.  Non-Invasive Monitoring of CNS MHC-I Molecules in Ischemic Stroke Mice.

Authors:  Jing Xia; Ying Zhang; Huanhuan Zhao; Jie Wang; Xueren Gao; Jinpeng Chen; Bo Fu; Yuqing Shen; Fengqin Miao; Jianqiong Zhang; Gaojun Teng
Journal:  Theranostics       Date:  2017-07-08       Impact factor: 11.556

7.  G.A.M.E.: GPU-accelerated mixture elucidator.

Authors:  Alioune Schurz; Bo-Han Su; Yi-Shu Tu; Tony Tsung-Yu Lu; Olivia A Lin; Yufeng J Tseng
Journal:  J Cheminform       Date:  2017-09-15       Impact factor: 5.514

8.  Deep learning model to predict complex stress and strain fields in hierarchical composites.

Authors:  Zhenze Yang; Chi-Hua Yu; Markus J Buehler
Journal:  Sci Adv       Date:  2021-04-09       Impact factor: 14.136

9.  Identification of a nanomolar affinity α-synuclein fibril imaging probe by ultra-high throughput in silico screening.

Authors:  John J Ferrie; Zsofia Lengyel-Zhand; Bieneke Janssen; Marshall G Lougee; Sam Giannakoulias; Chia-Ju Hsieh; Vinayak Vishnu Pagar; Chi-Chang Weng; Hong Xu; Thomas J A Graham; Virginia M-Y Lee; Robert H Mach; E James Petersson
Journal:  Chem Sci       Date:  2020-09-10       Impact factor: 9.969

Review 10.  Macromolecular modeling and design in Rosetta: recent methods and frameworks.

Authors:  Julia Koehler Leman; Brian D Weitzner; Steven M Lewis; Jared Adolf-Bryfogle; Nawsad Alam; Rebecca F Alford; Melanie Aprahamian; David Baker; Kyle A Barlow; Patrick Barth; Benjamin Basanta; Brian J Bender; Kristin Blacklock; Jaume Bonet; Scott E Boyken; Phil Bradley; Chris Bystroff; Patrick Conway; Seth Cooper; Bruno E Correia; Brian Coventry; Rhiju Das; René M De Jong; Frank DiMaio; Lorna Dsilva; Roland Dunbrack; Alexander S Ford; Brandon Frenz; Darwin Y Fu; Caleb Geniesse; Lukasz Goldschmidt; Ragul Gowthaman; Jeffrey J Gray; Dominik Gront; Sharon Guffy; Scott Horowitz; Po-Ssu Huang; Thomas Huber; Tim M Jacobs; Jeliazko R Jeliazkov; David K Johnson; Kalli Kappel; John Karanicolas; Hamed Khakzad; Karen R Khar; Sagar D Khare; Firas Khatib; Alisa Khramushin; Indigo C King; Robert Kleffner; Brian Koepnick; Tanja Kortemme; Georg Kuenze; Brian Kuhlman; Daisuke Kuroda; Jason W Labonte; Jason K Lai; Gideon Lapidoth; Andrew Leaver-Fay; Steffen Lindert; Thomas Linsky; Nir London; Joseph H Lubin; Sergey Lyskov; Jack Maguire; Lars Malmström; Enrique Marcos; Orly Marcu; Nicholas A Marze; Jens Meiler; Rocco Moretti; Vikram Khipple Mulligan; Santrupti Nerli; Christoffer Norn; Shane Ó'Conchúir; Noah Ollikainen; Sergey Ovchinnikov; Michael S Pacella; Xingjie Pan; Hahnbeom Park; Ryan E Pavlovicz; Manasi Pethe; Brian G Pierce; Kala Bharath Pilla; Barak Raveh; P Douglas Renfrew; Shourya S Roy Burman; Aliza Rubenstein; Marion F Sauer; Andreas Scheck; William Schief; Ora Schueler-Furman; Yuval Sedan; Alexander M Sevy; Nikolaos G Sgourakis; Lei Shi; Justin B Siegel; Daniel-Adriano Silva; Shannon Smith; Yifan Song; Amelie Stein; Maria Szegedy; Frank D Teets; Summer B Thyme; Ray Yu-Ruei Wang; Andrew Watkins; Lior Zimmerman; Richard Bonneau
Journal:  Nat Methods       Date:  2020-06-01       Impact factor: 28.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.